These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31297673)

  • 1. ASO Author Reflections: Toward Molecularly-Driven Personalized Care for Young Adults with Rectal Cancer.
    Yang Y; You YN
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):656-657. PubMed ID: 31297673
    [No Abstract]   [Full Text] [Related]  

  • 2. Rectal Cancer: Time for Precision Medicine?
    Weiser MR
    Ann Surg Oncol; 2016 Jan; 23(1):12-5. PubMed ID: 26323994
    [No Abstract]   [Full Text] [Related]  

  • 3. Current issues of preoperative radio(chemo)therapy and its future evolution in locally advanced rectal cancer.
    Ma B; Xu Q; Song Y; Gao P; Wang Z
    Future Oncol; 2017 Nov; 13(27):2489-2501. PubMed ID: 29124955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
    Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
    Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.
    Carpinetti P; Donnard E; Bettoni F; Asprino P; Koyama F; Rozanski A; Sabbaga J; Habr-Gama A; Parmigiani RB; Galante PA; Perez RO; Camargo AA
    Oncotarget; 2015 Nov; 6(35):38360-71. PubMed ID: 26451609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASO Author Reflections: Analysis of PD-L1 Expression and Immunoscore in Colorectal Cancer.
    Yomoda T
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):658-659. PubMed ID: 31332636
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy.
    Saigusa S; Toiyama Y; Tanaka K; Inoue Y; Mori K; Ide S; Imaoka H; Kawamura M; Mohri Y; Kusunoki M
    Int J Clin Oncol; 2016 Apr; 21(2):350-358. PubMed ID: 26370256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.
    Lin CY; Hsieh PL; Chou CL; Yang CC; Lee SW; Tian YF; Shiue YL; Li WS
    Oncology; 2020; 98(8):549-557. PubMed ID: 32408308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASO Author Reflections: Revisiting Risk of Dissemination from Small Rectal Neuroendocrine Tumors.
    Folkert IW; Roses RE
    Ann Surg Oncol; 2020 Mar; 27(3):864-865. PubMed ID: 31749081
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: From Overtreatment to Risk-Adjusted Therapy of Rectal Carcinoma.
    Junginger T
    Ann Surg Oncol; 2020 Feb; 27(2):428-429. PubMed ID: 31659643
    [No Abstract]   [Full Text] [Related]  

  • 11. NPTX2 is associated with neoadjuvant therapy response in rectal cancer.
    Karagkounis G; Thai L; DeVecchio J; Gantt GA; Duraes L; Pai RK; Kalady MF
    J Surg Res; 2016 May; 202(1):112-7. PubMed ID: 27083956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of growth pattern and tumor regression identifies a high-risk group in neoadjuvant treated rectal cancer patients.
    Jessberger J; Erlenbach-Wünsch K; Posselt R; Haderlein M; Agaimy A; Fietkau R; Hartmann A; Distel L
    J Dig Dis; 2017 May; 18(5):283-291. PubMed ID: 28342240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.
    Hongo K; Kazama S; Tsuno NH; Ishihara S; Sunami E; Kitayama J; Watanabe T
    World J Surg Oncol; 2015 Jan; 13():7. PubMed ID: 25622595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer.
    Conde-Muíño R; Cuadros M; Zambudio N; Segura-Jiménez I; Cano C; Palma P
    Biomed Res Int; 2015; 2015():921435. PubMed ID: 26504848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines.
    Gock M; Mullins CS; Bergner C; Prall F; Ramer R; Göder A; Krämer OH; Lange F; Krause BJ; Klar E; Linnebacher M
    World J Gastroenterol; 2018 Nov; 24(43):4880-4892. PubMed ID: 30487698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
    Kamel HFM; Al-Amodi HSAB
    Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer.
    Valentini V; van Stiphout RG; Lammering G; Gambacorta MA; Barba MC; Bebenek M; Bonnetain F; Bosset JF; Bujko K; Cionini L; Gerard JP; Rödel C; Sainato A; Sauer R; Minsky BD; Collette L; Lambin P
    Radiother Oncol; 2015 Mar; 114(3):302-9. PubMed ID: 25716096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment TACC3 expression in locally advanced rectal cancer decreases the response to neoadjuvant chemoradiotherapy.
    Ma WJ; Gu YK; Peng JH; Wang XC; Yue X; Pan ZZ; Chen G; Xu HN; Zhou ZG; Zhang RX
    Aging (Albany NY); 2018 Oct; 10(10):2755-2771. PubMed ID: 30341253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer.
    Buijsen J; van Stiphout RG; Menheere PP; Lammering G; Lambin P
    Radiother Oncol; 2014 May; 111(2):237-42. PubMed ID: 24746569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer.
    Shioya M; Takahashi T; Ishikawa H; Sakurai H; Ebara T; Suzuki Y; Saitoh J; Ohno T; Asao T; Kuwano H; Nakano T
    J Radiat Res; 2011; 52(6):821-7. PubMed ID: 22104271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.